Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HM Health Solutions, commonly abbreviated HMHS, was a healthcare technology and operations company serving health insurers and other payer organizations. It operated as a wholly owned subsidiary of Highmark Health and provided administrative, claims, digital, infrastructure, and business-process solutions for health plans. The business was not a drug developer or biotech company; instead, it focused on health-plan enablement, payer operations, and enterprise technology platforms. More recently, Highmark Health has described the business as having been renamed enGen, a health technology subsidiary supporting health plans and provider partners. For biotech and pharma diligence purposes, HM Health Solutions should be classified as a healthcare IT and payer-services company rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HM Health Systems.